Cover Image

Establishing a process for the use of hydroxyurea in pediatric sickle cell patients in Angola

Saved in:

Bibliographic Details
Main Authors:	R. Beaty (Author), G. Airewele (Author), D. Nirenberg (Author), M.P. Noli (Author), S. Kahan (Author), E. Ishigami (Author), M. Cubbage (Author), W. Zhang (Author), K. Wilson-Lewis (Author)
Format:	Book
Published:	Ubiquity Press, 2016-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pilot program of newborn screening for sickle cell disease in angola- Angola Sickle Cell Initiative (ASCI)
by: D. Nirenberg, et al.
Published: (2015)

Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea
by: Belkis Lázara Rodríguez Jorge, et al.
Published: (2021)

Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea
by: Belkis Lázara Rodríguez Jorge, et al.
Published: (2021)

Hydroxyurea for sickle-cell anaemia in Africa: mind the gap
by: Stephen K Obaro
Published: (2015)

Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease
by: Daniela Di Grazia, et al.
Published: (2024)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
by: Akancha Pandey, et al.
Published: (2022)

Hydroxyurea-Induced Cutaneous Ulcers in a Sickle Cell Disease Patient
by: Mayur S. Dudhe, et al.
Published: (2023)

Developing a logistical plan for deploying full and part-time healthcare providers abroad - Texas Children's Cancer and Hematology Centers's experience
by: E. Ishigami, et al.
Published: (2016)

Leveraging mathematical modeling to analyze nonadherence for hydroxyurea therapy in sickle cell disease
by: Akancha Pandey, et al.
Published: (2023)

Influence of hydroxyurea on the severity of acute chest syndrome in patients with sickle cell disease
by: Carlos González-Pérez, et al.
Published: (2022)

Cytotoxicity and DNA damage in the neutrophils of patients with sickle cell anaemia treated with hydroxyurea
by: Alano Martins Pedrosa, et al.
Published: (2014)

Survival and mortality among users and non-users of hydroxyurea with sickle cell disease
by: Olinda Maria Rodrigues de Araujo, et al.
Published: (2015)

Methemoglobin measure in adult patients with sickle-cell anemia: influence of hydroxyurea therapy
by: Marilia Rocha Laurentino, et al.
Published: (2014)

Dental Caries in Children with Sickle Cell Disease and Its Association with the Use of Hydroxyurea and Penicillin Prophylaxis in Dar Es Salaam
by: Minja IK, et al.
Published: (2024)

Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review
by: Joelma Santana dos Santos Neres, et al.
Published: (2023)

Attitudes of Primary Care Physicians Toward Sickle Cell Disease Care, Guidelines, and Comanaging Hydroxyurea With a Specialist
by: Joseph Lunyera, et al.
Published: (2017)

Standardization method for measurement of hydroxyurea by Ultra High Efficiency Liquid Chromatography in plasma of patients with sickle cell disease
by: Darcielle Bruna Dias Elias, et al.
Published: (2014)

A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study
by: Creary, Susan, et al.
Published: (2019)

Influence of Oxidative Stress Biomarkers and Genetic Polymorphisms on the Clinical Severity of Hydroxyurea-Free Senegalese Children with Sickle Cell Anemia
by: Fatou Gueye Tall, et al.
Published: (2020)

Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach
by: Alberts, Nicole M, et al.
Published: (2020)

Hydroxyurea-induced melanonychia
by: Michael G. Buontempo, BS, et al.
Published: (2023)

Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease
by: Manu GP, et al.
Published: (2022)

Hidroxiurea en el tratamiento de niños y adolescentes con depranocitosis Hydroxyurea in the treatment of children and adolescents with sickle cell anemia
by: Gretel González Gilart, et al.
Published: (2012)

Methodology and process for assessing feasibility of introducing pediatric hematology/oncology services in a resource-limited setting: Experience in Sub-Saharan Africa
by: K. Wilson-Lewis, et al.
Published: (2015)

Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response
by: Sètondji Cocou Modeste Alexandre Yahouédéhou, et al.
Published: (2020)

Understanding patient-related barriers to hydroxyurea use among adolescent and adult patients with sickle cell disease in Mulago and Kiruddu hospitals, Uganda, a qualitative study
by: Priscilla Namaganda, et al.
Published: (2024)

Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis
by: Rahyssa Rodrigues Sales, et al.
Published: (2022)

HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol
by: Arlene Smaldone, et al.
Published: (2019)

Oral lesions associated with hydroxyurea treatment
by: Regina Mendonça, et al.
Published: (2011)

Efficacy of hydroxyurea in ? thalassemia major patients
by: Nikitha Lakkakula, et al.
Published: (2024)

Establishing sickle cell diagnostics in Malawi using hemoglobin electrophoresis
by: J.B. Heimlich, et al.
Published: (2016)

Biochemical Evaluation of the Effects of Hydroxyurea in Vitro on Red Blood Cells
by: Cristiane Oliveira Renó, et al.
Published: (2021)

Hydroxyurea and pertussis: Unveiling new therapeutic possibilities
by: Mukul Kumar Sonava, et al.
Published: (2024)

Protective Effect of Apple Cider Vinegar in Hydroxyurea Treated Mice
by: R.S. Ayoub, et al.
Published: (2005)

Squamous Cell Carcinoma as a Complication of Long-Term Hydroxyurea Treatment
by: Miłosz Lewandowski, et al.
Published: (2021)

Syndrome of Inappropriate Antidiuretic Hormone secretion due to hydroxyurea
by: Hakan Ozer, et al.
Published: (2022)

Hydroxyurea-associated multiple squamous cell carcinoma developed on the dermatomyositis-like eruption
by: Omer Kutlu, et al.
Published: (2023)

Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells
by: Azam Akbari, et al.
Published: (2020)

Ashy dermatosis-like hyperpigmentation in a patient taking hydroxyurea
by: Stephen Li, PhD, et al.
Published: (2020)

Hydroxyurea-Loaded Albumin Nanoparticles: Preparation, Characterization, and In Vitro Studies
by: Yerkeblan Tazhbayev, et al.
Published: (2019)